OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Ron H.J. Mathijssen, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 10, pp. 1333-1364
Open Access | Times Cited: 28
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Ron H.J. Mathijssen, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 10, pp. 1333-1364
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in Cancer
Arthur Géraud, David Combarel, Christian Funck‐Brentano, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 678-689
Closed Access | Times Cited: 7
Arthur Géraud, David Combarel, Christian Funck‐Brentano, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 678-689
Closed Access | Times Cited: 7
Performance Comparison of Liquid Chromatography and Paper Spray Ionization with Mass Spectrometry for Measuring Kinase Inhibitors in Human Plasma
Richard G. Lahr, M. Joseph Meyer, Leah Nelson, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 557-565
Open Access
Richard G. Lahr, M. Joseph Meyer, Leah Nelson, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 557-565
Open Access
Advancing Src Kinase Inhibition: From Structural Design to Therapeutic Innovation - A Comprehensive Review
Yifeng Su, Kun Zhu, Jiahao Wang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117369-117369
Closed Access
Yifeng Su, Kun Zhu, Jiahao Wang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117369-117369
Closed Access
From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology
Bram C. Agema, Birgit C. P. Koch, Ron H.J. Mathijssen, et al.
Drugs (2025)
Open Access
Bram C. Agema, Birgit C. P. Koch, Ron H.J. Mathijssen, et al.
Drugs (2025)
Open Access
Development and validation of a UPLC-MS/MS method for almonertinib with its active metabolite HAS-719 and anlotinib in human plasma
Yi Qin, Xiaojun Guan, Shaonan Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116766-116766
Closed Access
Yi Qin, Xiaojun Guan, Shaonan Zhang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116766-116766
Closed Access
[Real-world Study of Icotinib in EGFR Mutant Non-small Cell Lung Cancer
Based on the Therapeutic Drug Monitoring].
Sen Han, Lan Mi, Jian Fang, et al.
PubMed (2025) Vol. 28, Iss. 1, pp. 33-39
Closed Access
Sen Han, Lan Mi, Jian Fang, et al.
PubMed (2025) Vol. 28, Iss. 1, pp. 33-39
Closed Access
Clinical Application of Volumetric Absorptive Microsampling for Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs
Marinda Meertens, Nikki Kerssemakers, Niels de Vries, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Marinda Meertens, Nikki Kerssemakers, Niels de Vries, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Recent Advances in Therapeutic Drug Monitoring of Antineoplastic and Antimicrobial Agents in Children
Alejandro R. Molinelli, Shane J. Cross, Markos Leggas
Clinics in Laboratory Medicine (2025)
Closed Access
Alejandro R. Molinelli, Shane J. Cross, Markos Leggas
Clinics in Laboratory Medicine (2025)
Closed Access
Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital‐Based Towards Home‐Sampling
Marinda Meertens, Hilde Rosing, Neeltje Steeghs, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 5
Open Access
Marinda Meertens, Hilde Rosing, Neeltje Steeghs, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 5
Open Access
Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
Hayato Yokota, Kazuhiro Sato, S. Sakamoto, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Open Access
Hayato Yokota, Kazuhiro Sato, S. Sakamoto, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Open Access
Exposure–Response Relationships for Toceranib in Dogs with Solid Tumors: A Pilot Study
Young-Rok Kim, Ji-Hwan Park, Kieun Bae, et al.
Animals (2025) Vol. 15, Iss. 7, pp. 1025-1025
Open Access
Young-Rok Kim, Ji-Hwan Park, Kieun Bae, et al.
Animals (2025) Vol. 15, Iss. 7, pp. 1025-1025
Open Access
Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology Platform
Hans Lennernäs, Magnus Brisander, Charlotta Liljebris, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 9, pp. 985-999
Open Access | Times Cited: 4
Hans Lennernäs, Magnus Brisander, Charlotta Liljebris, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 9, pp. 985-999
Open Access | Times Cited: 4
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method
Bianca Posocco, Martina Zanchetta, Marco Orleni, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 4, pp. 485-493
Open Access | Times Cited: 3
Bianca Posocco, Martina Zanchetta, Marco Orleni, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 4, pp. 485-493
Open Access | Times Cited: 3
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data
Cedric Lau, Ma Ida Mohmaed Ali, Lishi Lin, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 1, pp. 25-34
Open Access | Times Cited: 2
Cedric Lau, Ma Ida Mohmaed Ali, Lishi Lin, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 1, pp. 25-34
Open Access | Times Cited: 2
Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study
Anne Ravix, Carole Bandiera, Evelina Cardoso, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2193-2193
Open Access | Times Cited: 2
Anne Ravix, Carole Bandiera, Evelina Cardoso, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2193-2193
Open Access | Times Cited: 2
Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails
Niels A.D. Guchelaar, Maud B. A. van der Kleij, Neeltje Steeghs, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 504-505
Closed Access | Times Cited: 2
Niels A.D. Guchelaar, Maud B. A. van der Kleij, Neeltje Steeghs, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 504-505
Closed Access | Times Cited: 2
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Marinda Meertens, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 5, pp. 843-851
Open Access | Times Cited: 2
Maud B. A. van der Kleij, Niels A.D. Guchelaar, Marinda Meertens, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 5, pp. 843-851
Open Access | Times Cited: 2
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring
Eleonora Cecchin, Marco Orleni, Sara Gagno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10453-10453
Open Access | Times Cited: 1
Eleonora Cecchin, Marco Orleni, Sara Gagno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10453-10453
Open Access | Times Cited: 1
Mass Spectrometry in Clinical Chemistry: Advancing Biomarker Discovery and Personalized Medicine
Ahrum Son, Woojin Kim, Jongham Park, et al.
(2024)
Open Access | Times Cited: 1
Ahrum Son, Woojin Kim, Jongham Park, et al.
(2024)
Open Access | Times Cited: 1
Melt-blown polypropylene nonwoven as an efficient and eco-economic sorbent for pipette tip micro-solid phase extraction for the determination of tyrosine kinase inhibitors
Jing Ye, Yuanyuan Zheng, Xiangyu Li, et al.
Analytica Chimica Acta (2024) Vol. 1329, pp. 343240-343240
Closed Access | Times Cited: 1
Jing Ye, Yuanyuan Zheng, Xiangyu Li, et al.
Analytica Chimica Acta (2024) Vol. 1329, pp. 343240-343240
Closed Access | Times Cited: 1
Can therapeutic drug monitoring of lorlatinib help us design the right CROWN?
Molly Li, Ross A. Soo
Lung Cancer (2024), pp. 107965-107965
Closed Access | Times Cited: 1
Molly Li, Ross A. Soo
Lung Cancer (2024), pp. 107965-107965
Closed Access | Times Cited: 1
LC-MS/MS method for quantification of 23 TKIs in Plasma: Assessing the relationship between anlotinib trough concentration and toxicities
Chen Bu, Liansheng Jiang, Lili Cui, et al.
Clinica Chimica Acta (2024) Vol. 566, pp. 120028-120028
Closed Access | Times Cited: 1
Chen Bu, Liansheng Jiang, Lili Cui, et al.
Clinica Chimica Acta (2024) Vol. 566, pp. 120028-120028
Closed Access | Times Cited: 1
Are novel oral oncolytics underdosed in obese patients?
Lishi Lin, Ellen K. O. van der Meer, Neeltje Steeghs, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 2, pp. 129-136
Open Access | Times Cited: 2
Lishi Lin, Ellen K. O. van der Meer, Neeltje Steeghs, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 93, Iss. 2, pp. 129-136
Open Access | Times Cited: 2
Preliminary Investigation of a Rapid and Feasible Therapeutic Drug Monitoring Method for the Real-Time Estimation of Blood Pazopanib Concentrations
Masaru Kato, S. Maruyama, Noriko Watanabe, et al.
The AAPS Journal (2024) Vol. 26, Iss. 3
Closed Access
Masaru Kato, S. Maruyama, Noriko Watanabe, et al.
The AAPS Journal (2024) Vol. 26, Iss. 3
Closed Access
